AU4635885A - Compounds for site-enhanced delivery of radionuclides and uses thereof - Google Patents
Compounds for site-enhanced delivery of radionuclides and uses thereofInfo
- Publication number
- AU4635885A AU4635885A AU46358/85A AU4635885A AU4635885A AU 4635885 A AU4635885 A AU 4635885A AU 46358/85 A AU46358/85 A AU 46358/85A AU 4635885 A AU4635885 A AU 4635885A AU 4635885 A AU4635885 A AU 4635885A
- Authority
- AU
- Australia
- Prior art keywords
- radionuclides
- site
- compounds
- enhanced delivery
- enhanced
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63231484A | 1984-07-19 | 1984-07-19 | |
US632314 | 1984-07-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4635885A true AU4635885A (en) | 1986-02-25 |
Family
ID=24535023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU46358/85A Abandoned AU4635885A (en) | 1984-07-19 | 1985-07-15 | Compounds for site-enhanced delivery of radionuclides and uses thereof |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0187832A1 (en) |
JP (1) | JPS61106556A (en) |
KR (1) | KR900007514B1 (en) |
AU (1) | AU4635885A (en) |
CA (1) | CA1267899A (en) |
DK (1) | DK124786A (en) |
ES (1) | ES8704900A1 (en) |
FI (1) | FI861118A0 (en) |
GR (1) | GR851792B (en) |
NO (1) | NO860981L (en) |
PT (1) | PT80841B (en) |
WO (1) | WO1986000898A1 (en) |
ZA (1) | ZA855476B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5079366A (en) * | 1987-04-07 | 1992-01-07 | University Of Florida | Quarternary pyridinium salts |
US4888427A (en) * | 1987-04-07 | 1989-12-19 | University Of Florida | Amino acids containing dihydropyridine ring systems for site-specific delivery of peptides to the brain |
DE3879024T2 (en) * | 1987-07-31 | 1993-10-07 | Takeda Chemical Industries Ltd | Pyridinium derivatives, their production and use. |
DE4107570A1 (en) * | 1991-03-07 | 1992-11-19 | Diagnostikforschung Inst | CHELATES, THEIR METAL COMPLEXES AND THEIR USE IN DIAGNOSTICS AND THERAPY |
JP4677863B2 (en) * | 2005-09-05 | 2011-04-27 | 堺化学工業株式会社 | Thiol-based photocurable monomer and photocurable resin composition |
US8701166B2 (en) | 2011-12-09 | 2014-04-15 | Blackberry Limited | Secure authentication |
US10864279B2 (en) * | 2016-12-16 | 2020-12-15 | Industrial Technology Research Institute | Linker-drug and antibody-drug conjugate (ADC) employing the same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0110955B1 (en) * | 1982-05-18 | 1995-08-23 | University Of Florida | Brain-specific drug delivery |
-
1985
- 1985-07-15 WO PCT/US1985/001334 patent/WO1986000898A1/en not_active Application Discontinuation
- 1985-07-15 AU AU46358/85A patent/AU4635885A/en not_active Abandoned
- 1985-07-15 EP EP85903633A patent/EP0187832A1/en not_active Withdrawn
- 1985-07-18 GR GR851792A patent/GR851792B/el unknown
- 1985-07-18 KR KR1019850005137A patent/KR900007514B1/en not_active IP Right Cessation
- 1985-07-19 PT PT80841A patent/PT80841B/en unknown
- 1985-07-19 CA CA000487165A patent/CA1267899A/en not_active Expired - Fee Related
- 1985-07-19 ZA ZA855476A patent/ZA855476B/en unknown
- 1985-07-19 JP JP60160040A patent/JPS61106556A/en active Pending
-
1986
- 1986-02-17 ES ES552072A patent/ES8704900A1/en not_active Expired
- 1986-03-14 NO NO860981A patent/NO860981L/en unknown
- 1986-03-18 FI FI861118A patent/FI861118A0/en not_active Application Discontinuation
- 1986-03-18 DK DK124786A patent/DK124786A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPS61106556A (en) | 1986-05-24 |
NO860981L (en) | 1986-05-20 |
FI861118A (en) | 1986-03-18 |
WO1986000898A1 (en) | 1986-02-13 |
KR900007514B1 (en) | 1990-10-11 |
DK124786D0 (en) | 1986-03-18 |
ES8704900A1 (en) | 1987-04-16 |
KR860000871A (en) | 1986-02-20 |
FI861118A0 (en) | 1986-03-18 |
GR851792B (en) | 1985-11-26 |
CA1267899A (en) | 1990-04-17 |
PT80841B (en) | 1987-06-03 |
ZA855476B (en) | 1987-03-25 |
EP0187832A1 (en) | 1986-07-23 |
DK124786A (en) | 1986-05-20 |
PT80841A (en) | 1985-08-01 |
ES552072A0 (en) | 1987-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3565937D1 (en) | Medical composition for external application | |
PH22863A (en) | Pyrrolobenzimidazoles and pharmaceutical composition containing them | |
IL74758A0 (en) | Acyltripeptides and pharmaceutical compositions containing them | |
AU4177785A (en) | Polyaminodithiols and radiopharmaceuticals | |
EP0173990A3 (en) | External pharmaceutical composition | |
GB2153678B (en) | Pharmaceutical composition | |
AU4893385A (en) | Stabilized composition containing inositoltriphosphate | |
EP0163178A3 (en) | Pharmaceutical composition | |
AU4454389A (en) | Pharmaceutical composition | |
PH21185A (en) | 9a-aza-9a-homoerythromycin derivatives and pharmaceutical composition containing them | |
AU578068B2 (en) | Hydantoin derivatives and pharmaceutical compositions containing them | |
PH23447A (en) | B-actam compounds,pharmaceutical compositions containing the same and method of use thereof | |
GB2153677B (en) | Pharmaceutical composition | |
DE3568578D1 (en) | Beta-lactam compound and preparing thereof | |
NZ225466A (en) | 1-aminoalkyl-1h-indole derivatives and pharmaceutical compositions containing certain derivatives thereof | |
PH21022A (en) | Phenylquinoline derivatives and pharmaceutical composition containing said compounds | |
AU4635885A (en) | Compounds for site-enhanced delivery of radionuclides and uses thereof | |
GB8523491D0 (en) | Medicinal composition | |
NZ214048A (en) | Cephalosporins and pharmaceutical compositions | |
PH21046A (en) | Imidazole derivatives and pharmaceutical composition containing said compound | |
PH25904A (en) | Polycyclic compounds and pharmaceutical formulations containing them | |
IL74667A (en) | Spiro-oxazolidones,-thiazolidones and-imidazolidones and pharmaceutical compositions containing them | |
AU564702B2 (en) | Novel radioactive iodospiroperidol and process for its preparation | |
DE3565833D1 (en) | Sulphureous hydantoin derivatives and pharmaceutical compositions containing them | |
AU535385B2 (en) | N-derivatives of azaspiroalkanediones |